Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
following evidence that the dye causes cancer in laboratory rats. The ban by the Foodand DrugAdministration on the Red No. 3 dye in food items comes more than three decades after it was ...
Some results have been hidden because they may be inaccessible to you